A medtech company arrives in the NHS with what appears to be a breakthrough. The procedure is less invasive. The device is clever. Recovery may be faster. The surgeon can …
News
-
-
News
WHY YOU NEED TO THINK before using AI: A Framework for Preserving Critical Thinking in the Age of Artificial Intelligence
Overview Recent research demonstrates a critical insight that should reshape how individuals and organisations approach artificial intelligence: the timing, context, and intentionality behind AI use fundamentally determine whether these tools …
-
Indirect Treatment Comparisons in France: Why HAS Exposes the Limits of Multi-Market Evidence Strategies For over a decade, market access teams have observed a persistent pattern: indirect treatment comparisons (ITCs) …
-
A Structural Shift in Evidence Generation for Medicines and Medical Technologies The implementation of the EU Health Technology Assessment Regulation (HTAR, 2021/2282) marks a fundamental transition in how clinical and …
-
What It Is, How It Works, and What Success Actually Requires Introduction: The Hidden Architecture of French Reimbursement In France, a single institution holds the power to determine whether a …
-
DiappyMed and Sanofi Partnership: Transforming Digital Diabetes Care in France DiappyMed’s €5 million seed funding round and strategic partnership with pharmaceutical giant Sanofi represent a pivotal moment for digital therapeutics …
-
Comprehensive guide to DTx reimbursement in France. Learn how digital therapeutics (DTx) navigate CNEDiMTS evaluation, PECAN requirements, and scientific methodology standards for HAS approval. The Urgency of Securing HAS Approval …
-
The European framework for digital health technology assessment represents a watershed moment for innovation companies seeking reimbursement across fragmented national systems[1][5]. Rather than navigating each country’s unique evaluation pathway from …
-
Why 68% of Diagnostic AI Companies Leave 3-5x Valuation on the Table. How to Compress AI Diagnostic Procurement From 12 Months to 4 Months. AI Diagnostic Revenue Gap: Why Evidence …
-
Norway’s FlowOx Approval 2026: Complete Health Technology Assessment & Procurement Guide. The Brilliance of Iacob Mathieson. Discover how Norway approved FlowOx for peripheral arterial disease. Explore the evidence, HTA framework, …